Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | May 18, 2012

Ongoing royalty same as jury verdict where circumstances had not changed

Blog | May 17, 2012

Recent Articles on Patent Damages

Blog | May 15, 2012

EDTX Post-Trial Order on Multiple Issues: Ongoing Royalty Base and Payment of Ongoing Royalties; Supplemental Damages & Prejudgment Interest; Foreign Tax Laws; Extending Ongoing Royalties to Successors and Assigns; Stay of Supplemental Damages and Ongoing Royalties Pending Appeal

Article | May 08, 2012

The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector

Blog | May 07, 2012

Lost Profits Rejected Where Patentee Failed to Prove It "Would Have Made" a Competing Product Absent the Alleged Infringement

Blog | May 04, 2012

CAFC: Matter of First Impression Settlement—Negotiations Are Discoverable

Blog | May 04, 2012

NDCA Allows Use of Nash Bargaining as "Check" on Royalty Rate; Rejects Use of EMVR Because Accused Products only "Capable" of Infringement

Blog | May 02, 2012

EDTX Allows Defendant's Damages Reduction Based on Foreign Sales But Disallows in Part Defendant's Government Sales Reduction

Blog | April 25, 2012

Oracle v. Google: NDCA Rejects Conclusions by Court-Appointed Damages Expert Because They Failed to Account for the Value of the IP in Suit

Article | March 13, 2012

Biosimilars vs. Generics - Major Differences in the Regulatory Model

Blog | March 12, 2012

Daubert Motion granted on Price Erosion opinion

Blog | March 09, 2012

NDTX finds that Marking turns on what claims at issue in trial, not earlier asserted